Patients with elevated SLC7A11 expression show increased sensitivity to erastin-induced ferroptosis, whereas SLC7A11 knockdown significantly inhibits MM proliferation and induces ferroptotic cell death. Here, SLC7A11 is linked to Miyoshi myopathy.